Following period 1 , there were significant least-squares ( LS ) mean reductions in 24-h WMG of 32.8 mg/dl , significant LS mean reduction from baseline in MDG of 28 mg/dl , FPG of 20.3 mg/dl and fructosamine of 33.7 mmol/l in patients treated with sitagliptin relative to placebo ( p < 0.05 ) .
